文献速递糖尿病

提高糖化血红蛋白达标时间可减少老年糖尿病患者不良健康结局

Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes.
PubMed 文献 · Diabetes Care · 2021-06-14

该回顾性观察研究纳入402,043名≥65岁、有糖尿病且基线3年内至少检测4次A1C的退伍军人,评估个体化A1C目标范围内时间百分比(A1C TIR)与死亡和心血管疾病的关系。平均随访5.5年发现,A1C TIR与死亡和CVD呈分级关系,低A1C TIR与死亡和CVD风险增加相关。

要点

  • 在老年糖尿病患者中,A1C TIR与死亡率和心血管疾病风险呈分级负相关。
  • 与A1C TIR 80-100%相比,A1C TIR 0-<20%者死亡风险增加(HR 1.22,95%CI 1.20-1.25)。
  • 保持A1C在个体化目标范围内与较低的死亡和CVD风险相关。

核心结论

  • 在老年糖尿病患者中,维持A1C水平在个体化目标范围内与较低的死亡和心血管疾病风险相关。

研究设计与样本

  • 回顾性观察研究,使用2004至2016年美国退伍军人事务部和Medicare行政数据。
  • 纳入≥65岁糖尿病患者,基线3年内至少检测4次A1C,共402,043名退伍军人(平均年龄76.9岁,98.8%男性)。

主要发现

  • 平均随访5.5年,A1C TIR与死亡率和CVD呈分级关系。
  • 与A1C TIR 80-100%相比,A1C TIR 0-<20%者死亡率风险增加(HR 1.22,95%CI 1.20-1.25)。
  • 与A1C TIR 80-100%相比,A1C TIR 0-<20%者CVD风险增加(HR 1.14,95%CI 1.11-1.19)。
  • 竞争风险模型和较短随访(如24个月)显示相似结果。

关键数值与推荐

  • A1C TIR定义为基线期间A1C处于个体化目标范围(6.0-7.0%至8.0-9.0%)的天数百分比。
  • 个体化目标范围基于临床特征和预测预期寿命确定。
  • A1C TIR按20%增量分类。

临床怎么用

  • 对老年糖尿病患者,可基于临床特征和预期寿命设定个体化A1C目标范围。
  • 监测A1C TIR可能有助于评估血糖控制稳定性及不良结局风险。

局限性

  • 回顾性观察研究设计,无法确立因果关系。
  • 研究人群以男性退伍军人为主(98.8%),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Short- and long-term glycemic variability are risk factors for diabetes complications. However, there are no validated A1C target ranges or measures of A1C stability in older adults. We evaluated the association of a patient-specific A1C variability measure, A1C time in range (A1C TIR), on major adverse outcomes. RESEARCH DESIGN AND METHODS: We conducted a retrospective observational study using administrative data from the Department of Veterans Affairs and Medicare from 2004 to 2016. Patients were ≥65 years old, had diabetes, and had at least four A1C tests during a 3-year baseline period. A1C TIR was the percentage of days during the baseline in which A1C was in an individualized target range (6.0-7.0% up to 8.0-9.0%) on the basis of clinical characteristics and predicted life expectancy. Increasing A1C TIR was divided into categories of 20% increments and linked to mortality and cardiovascular disease (CVD) (i.e., myocardial infarction, stroke). RESULTS: The study included 402,043 veterans (mean [SD] age 76.9 [5.7] years, 98.8% male). During an average of 5.5 years of follow-up, A1C TIR had a graded relationship with mortality and CVD. Cox proportional hazards models showed that lower A1C TIR was associated with increased mortality (A1C TIR 0 to <20%: hazard ratio [HR] 1.22 [95% CI 1.20-1.25]) and CVD (A1C TIR 0 to <20%: HR 1.14 [95% CI 1.11-1.19]) compared with A1C TIR 80-100%. Competing risk models and shorter follow-up (e.g., 24 months) showed similar results. CONCLUSIONS: In older adults with diabetes, maintaining A1C levels within individualized target ranges is associated with lower risk of mortality and CVD.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Prentice JC, Mohr DC, Zhang L, et al. Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes. Diabetes Care. 2021. PMID: 34127496. doi:10.2337/dc21-0292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。